Long-term efficacy of preoperative radiotherapy for locally advanced low rectal cancer.
OBJECTIVE
The purpose of this study was to assess the long-term efficacy of preoperative radiotherapy for locally advanced low rectal cancer.


METHODS
Between April 1990 and June 2005, all patients who underwent surgery for low rectal cancer with a pretreatment diagnosis of T3 or resectable T4 without distant metastasis were enrolled. The total dose of radiation was 45 Gy. Patients with a partial or complete response were defined as radiotherapy responders (RT-R) and the others as radiotherapy non-responders (RT-NR). Patients who did not receive radiotherapy were termed the non-radiotherapy group (NRT). The endpoint of this study was overall survival and local and/or distant metastasis.


RESULTS
There were 24 patients in RT-R, 26 in RT-NR, and 40 in NRT. Gastrointestinal complications were commonly observed in all groups. RT-R had a significantly higher incidence of genitourinary complications. Five-year overall survival rate was 79.6% in RT-R, 58.9% in RT-NR, and 58.8% in NRT. The difference was significant in favor of RT-R over the others (P=0.015, 0.024, respectively). Five-year local recurrence-free survival rate was 100% in RT-R, 81.5% in RT-NR, and 74.9% in NRT. RT-R had significantly improved local control compared with the others (P=0.034, 0.021, respectively). Five-year distant metastasis-free survival was not statistically different among all groups.


CONCLUSIONS
Survival benefit of preoperative radiotherapy was limited to responders. Considering the increased risk of adverse effects, identification of predictors of radiosensitivity is required in order to provide the most suitable treatment for individual patients.
Tsujinaka
Shingo
S
Department of Surgery, Jichi Medical University Omiya Medical Center, 1-847, Amanumacho, Omiya, Saitama-shi, Saitama 330-8503, Japan. tsujinakas@omiya.jichi.ac.jp
Kawamura
Yutaka J
YJ
Konishi
Fumio
F
Aihara
Hiroyuki
H
Maeda
Takafumi
T
Mizokami
Ken
K
D000328:Adult; D000368:Aged; D013505:Digestive System Surgical Procedures / Q000009:adverse effects; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy / Q000009:adverse effects; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D011829:Radiation Dosage; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects; D012004:Rectal Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D012189:Retrospective Studies; D018570:Risk Assessment; D013997:Time Factors; D016896:Treatment Outcome
J Clin Oncol. 2006 Oct 1;24(28):4620-5
17008704
Eur J Surg Oncol. 2006 Feb;32(1):55-64
16324817
J Natl Cancer Inst. 2000 Feb 2;92 (3):205-16
10655437
N Engl J Med. 1997 Apr 3;336(14 ):980-7
9091798
Arch Surg. 1998 Aug;133(8):894-9
9711965
N Engl J Med. 2001 Aug 30;345(9):638-46
11547717
J Natl Cancer Inst. 1988 Mar 2;80(1):21-9
3276900
N Engl J Med. 2006 Sep 14;355(11):1114-23
16971718
Dis Colon Rectum. 2006 Nov;49(11):1663-72
17041749
Br J Surg. 2003 Aug;90(8):996-8
12905554
JAMA. 2000 Aug 23-30;284(8):1008-15
10944647
Clin Colorectal Cancer. 2006 Mar;5(6):413-21
16635280
J Clin Oncol. 2005 Dec 1;23(34):8697-705
16314629
Dis Colon Rectum. 2000 Oct;43(10 Suppl):S59-68
11052480
JAMA. 1990 Sep 19;264(11):1444-50
2202842
Cancer Res. 2006 Apr 1;66(7):3370-4
16585155
Br J Surg. 2006 Oct;93(10):1215-23
16983741
Dis Colon Rectum. 1993 Jun;36(6):564-72
8500374
N Engl J Med. 2004 Oct 21;351(17):1731-40
15496622
Dis Colon Rectum. 2006 Mar;49(3):302-10
16456638
J Clin Oncol. 2005 Sep 1;23(25):6199-206
16135487
J Clin Oncol. 1999 Aug;17(8):2396
10561302
N Engl J Med. 1985 Jun 6;312(23 ):1465-72
2859523
Dis Colon Rectum. 2001 Sep;44(9):1274-80
11584199
Lancet. 2001 Oct 20;358(9290):1291-304
11684209